Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
ROUYN-NORANDA, Québec, 21 févr. 2023 (GLOBE NEWSWIRE) -- ENTREPRISES MINIÈRES GLOBEX INC. (GMX – Bourse de Toronto, G1MN – Bourses de Francfort, Stuttgart, Berlin, Munich, Tradegate, Lang...
-
ROUYN-NORANDA, Quebec, Feb. 21, 2023 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS...
-
The Draganfly team will be located at booth #8A29 to demonstrate how the company’s new Heavy Lift, Commander 3XL Drone, and Vital Intelligence Technology are used to enhance public safety. Dubai,...
-
The Draganfly team will be located at booth #1277, showcasing the company’s Vital Intelligence AI Technology, Heavy Lift Drone and Commander 3XL Drone Los Angeles, CA., Feb. 16, 2023 (GLOBE...
-
Draganfly’s Situational Assessment Drones will provide regions of Ukraine with intel, infrastructure assessments, and aid in search and rescue operations throughout the country. Los Angeles, CA.,...
-
22 % höhere Lizenzeinnahmen (Royalties) für Antipilzmedikament Cresemba®Betriebsgewinn in Höhe von CHF 18.5 Mio. und CHF 12.1 Mio. Konzerngewinn Verbesserte Bilanzstruktur nach nicht-verwässernder...
-
22% year-on-year increase of royalty income from antifungal Cresemba®Operating profit of CHF 18.5 million and net profit of CHF 12.1 millionStrengthened balance sheet through non-dilutive repayment of...
-
NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Elys Game Technology, Corp. (“Elys" or the “Company") (Nasdaq: ELYS)(BER:3UW), an interactive gaming and sports betting technology company, is pleased to...
-
NEW YORK, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Elys Game Technology, Corp. (“Elys" or the “Company") (Nasdaq: ELYS)(BER:3UW), an interactive gaming and sports betting technology company, is pleased to...
-
Basel/Allschwil, Switzerland, February 07, 2023Basilea Pharmaceutica Ltd. (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and...